About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

HDX Technology Provides Roadmap for Osteoporosis Treatment

by Anjali Aryamvally on October 15, 2017 at 11:06 AM
Font : A-A+

HDX Technology Provides Roadmap for Osteoporosis Treatment

A molecular model that may provide a new framework for improving the design of osteoporosis treatments was developed using advanced mass spectrometry technology. The study was conducted by a research team from the Florida campus of The Scripps Research Institute (TSRI) and the findings are published in the journal Nature Communications.

"Because of our aging population, these kinds of therapeutics are in great demand," said study leader Patrick R. Griffin, co-chair of the TSRI Department of Molecular Medicine. Using a technology known as HDX, which the Griffin lab has propelled into mainstream protein analysis, the scientists delivered the first dynamic snapshots of a prime target for osteoporosis treatments: a receptor that regulates calcium levels to maintain healthy bones.

Advertisement


The use of current drugs that target this receptor--called vitamin D receptor agonists--is limited because use can result in hypercalcemia, a condition that can weaken bones and even cause kidney stones, due to too much calcium in the bloodstream.

To address this problem, scientists need a clearer picture of the structure of the vitamin D receptor. The vitamin D receptor complex regulates bone mineralization by controlling a gene known as BGLAP that is the target of 1£\, 25-dihydroxyvitamin D3 (1,25D3), the active hormonal version of vitamin D. Unfortunately, increased levels of 1,25D3 also activate a calcium-regulating gene called TRPV6, which leads to hypercalcemia.
Advertisement

Griffin and his colleagues hope to eliminate this threat by developing 1,25D3 analogs (known as dissociated vitamin D receptor ligands or VDRMs) that differentially target BGLAP genes, while avoiding TRPV6.

"The idea is that if we could fingerprint how these various ligands interact with the vitamin D receptor, we could provide a kind of roadmap to help develop those that only trigger the non-hypercalcemia gene," Griffin said.

Until now, developing more selective compounds has been hampered by the fact that no one understood the structural mechanism that makes them work.

"This study shows it's possible to develop a drug that can alter certain aspects of the complex to avoid problematic activation of TRPV6 --and the study points to novel ways to design potential therapeutics to treat osteoporosis safely and more effectively," Griffin noted.

Griffin and his colleagues performed a detailed comparative biophysical study on hundreds of compounds, all with distinct chemical structures.

"Our results provide snapshots of distinct conformational ensembles of the receptor, which allows it to adopt different orientations depending on compound structure, DNA and co-activator binding," said TSRI Research Associate Jie Zheng, the first author of the study. "This study shows the molecular mechanism of a selective vitamin D receptor modulator versus agonists and how they drive different interactions with co-regulators when associated with sequence-specific DNAs."

The scientists used hydrogen-deuterium exchange (HDX) mass spectrometry, a high-precision, high-sensitivity mapping technique that has proven to be a robust method to probe protein conformational or shape changing dynamics within the context of ligand and protein/protein interactions.

HDX can show the specific regions of the protein complex that are altered on interaction with specific ligands, in this case the vitamin D receptor complex, information which can be used to infer structural changes that are the result of a specific interaction.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
Long-Term Glycemic Control - A Better Measure of COVID-19 Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Fracture Rickets Osteoporosis Lifestyle And Osteoporosis Kyphosis Colle’s Fracture Fracture Neck of Femur Back Pain at Workplace: Prevention and Exercises Screening for Osteoporosis Bone Health 

Recommended Reading
Lifestyle And Osteoporosis
Encyclopedia section of medindia briefly explains about Lifestyle and Osteoporosis...
Osteoporosis
Osteoporosis is a bone disease that leads to an increased risk of fractures. The bone mass is ......
Olive Oil and Its Benefits
The anti-inflammatory and anti-oxidant properties are responsible for the health benefits of olive ....
Screening for Osteoporosis
The risk of suffering from osteoporotic fractures is 30-50% in women and 15 to 30% in men. ......
Back Pain at Workplace: Prevention and Exercises
Understanding the basics about our back and our posture is very important in preventing back pain an...
Colle’s Fracture
Colles fracture or broken wrist is a wrist fracture, which occurs within an inch of the wrist joint....
Fracture
A fracture is a condition where the continuity of the bone is lost. Majority of bone fractures occur...
Kyphosis
Kyphosis is a spinal disorder, which is derived from Greek word – 'kyphos' which means bowed or ben...
Rickets
Encyclopedia section of medindia explains in brief about Rickets...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use